Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105541773A details a green synthesis route for 3,4-dihydro-4-arylcoumarins using recyclable catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel enzymatic synthesis route for HIV integrase inhibitor intermediates. High purity, scalable process offering significant supply chain stability and cost efficiency for pharmaceutical partners.
Patent CN115678953A details a green enzymatic route for high-purity cholesterol, offering superior isomer control and safety for reliable pharmaceutical intermediate supply chains.
Patent CN113443974A details a metal-free UV-catalyzed route to phenanthrene derivatives, offering cost reduction in electronic chemical manufacturing and high purity.
Patent CN117821355A reveals efficient enzymatic synthesis for ferulic acid. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Novel chiral Brønsted acid catalysis method for unnatural serine. Reduces cost and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN107445795A reveals a visible-light photocatalytic method for fluorinated aryl blocks. Enables cost reduction in agrochemical manufacturing and high-purity supply.
Patent CN102093166B details a scalable asymmetric synthesis of (S)-trans-1-yn-4-en-eicosan-3-ol with >97% ee, offering a reliable alternative to natural extraction for pharmaceutical applications.
Patent CN116159594A introduces a metal-free photocatalytic route for quinazolinones. This green method offers significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN118084596B enables visible light catalytic hydrogenation of aromatic olefins. Achieve high-purity intermediates with reduced costs and mild reaction conditions for scalable manufacturing.
Novel patent CN109651202A enables safe carbamate synthesis using CO2. Reduces toxicity risks and simplifies supply chain for pharmaceutical intermediates.
Patent CN108675955B reveals an aqueous chlorination route for 2-amino-5-chloropyridine, offering high purity for zopiclone synthesis and reduced environmental impact.
Patent CN109046405A enables efficient vitamin A acetate isomerization. Discover cost reduction in vitamin manufacturing and reliable supply chain solutions.
Patent CN101023077B details a high-yield phase transfer process for R-sertaconazole nitrate, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel aqueous phase transfer catalysis route for antiviral intermediates. Reduces VOCs, lowers cost, and ensures >98% purity for reliable supply chain.
Patent CN110218234A reveals safer Promestriene synthesis. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable solid acid catalysis.
Discover patented hafnium tetrachloride catalysis for aminophosphonates. Delivers high yields, mild conditions, and supply chain stability for pharmaceutical intermediates.
Patent CN109970705A details copper-catalyzed Ullmann coupling for high-purity epipiprazole intermediate, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101906445A reveals a mild enzymatic route for coumarin derivatives, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN103145689A details a cost-effective 5-step route to Fingolimod intermediates, offering significant supply chain stability and reduced manufacturing costs for global API producers.